Standout Papers
- Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology (2006)
- Bone Marrow–Derived Cells Do Not Contribute Significantly to Collagen I Synthesis in a Murine Model of Renal Fibrosis (2006)
- Evaluation of Methods for Sizing and Counting of Ultrasound Contrast Agents (2012)
- Microbubble Stability is a Major Determinant of the Efficiency of Ultrasound and Microbubble Mediated in vivo Gene Transfer (2009)
- Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles (2004)
Citation Impact
Citing Papers
rMATS: Robust and flexible detection of differential alternative splicing from replicate RNA-Seq data
2014 Standout
CRISPR-Pass: Gene Rescue of Nonsense Mutations Using Adenine Base Editors
2019
Transition from inflammation to proliferation: a critical step during wound healing
2016 Standout
Chronic Systemic Therapy With Low-dose Morpholino Oligomers Ameliorates the Pathology and Normalizes Locomotor Behavior in mdx Mice
2010
In Vivo Myogenic Potential of Human CD133+ Muscle-derived Stem Cells: A Quantitative Study
2009
Complete Genetic Correction of iPS Cells From Duchenne Muscular Dystrophy
2009 StandoutNobel
Revertant fibres and dystrophin traces in Duchenne muscular dystrophy: Implication for clinical trials
2010
Mechanisms of hypoxia signalling: new implications for nephrology
2019 StandoutNobel
Fibroblast activation and myofibroblast generation in obstructive nephropathy
2009
Antisense Masking of an hnRNP A1/A2 Intronic Splicing Silencer Corrects SMN2 Splicing in Transgenic Mice
2008
Fibroblasts and myofibroblasts in renal fibrosis
2011
The emerging role of lncRNAs in cancer
2015 Standout
TGF-β: the master regulator of fibrosis
2016 Standout
Programmable RNA Tracking in Live Cells with CRISPR/Cas9
2016 StandoutNobel
Long Noncoding RNAs in Cancer Pathways
2016 Standout
Multiexon skipping leading to an artificial DMD protein lacking amino acids from exons 45 through 55 could rescue up to 63% of patients with Duchenne muscular dystrophy
2006
In-frame Dystrophin Following Exon 51-Skipping Improves Muscle Pathology and Function in the Exon 52–Deficient mdx Mouse
2010
Targeting nuclear RNA for in vivo correction of myotonic dystrophy
2012 Nature
The chemokine receptor CXCR6 contributes to recruitment of bone marrow–derived fibroblast precursors in renal fibrosis
2014
Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy
2009 Standout
Renal erythropoietin-producing cells in health and disease
2015
The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells
2014 Standout
Exon Skipping and Duchenne Muscular Dystrophy Therapy: Selection of the Most Active U1 snRNA Antisense Able to Induce Dystrophin Exon 51 Skipping
2010
Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
2011 Standout
Origin of myofibroblasts and cellular events triggering fibrosis
2014
RNA therapeutics: beyond RNA interference and antisense oligonucleotides
2012 Nobel
Cellular and molecular mechanisms of renal fibrosis
2011 Standout
CXCL16 Recruits Bone Marrow-Derived Fibroblast Precursors in Renal Fibrosis
2011
Morpholinos and their peptide conjugates: Therapeutic promise and challenge for Duchenne muscular dystrophy
2010
Renal fibrosis is not reduced by blocking transforming growth factor-β signaling in matrix-producing interstitial cells
2015
Efficacy of systemic morpholino exon‐skipping in duchenne dystrophy dogs
2009
A Long Noncoding RNA Controls Muscle Differentiation by Functioning as a Competing Endogenous RNA
2011 Standout
Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study
2016 Standout
Mechanisms of Tubulointerstitial Fibrosis
2010
Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises
2011 Standout
One-year Treatment of Morpholino Antisense Oligomer Improves Skeletal and Cardiac Muscle Functions in Dystrophic mdx Mice
2010
Long non-coding RNAs: new players in cell differentiation and development
2013 Standout
Human Splicing Finder: an online bioinformatics tool to predict splicing signals
2009 Standout
Viral-mediated gene therapy for the muscular dystrophies: Successes, limitations and recent advances
2006
Exon-intron circular RNAs regulate transcription in the nucleus
2015 Standout
RNA and Disease
2009
Diverse Viruses Require the Calcium Transporter SPCA1 for Maturation and Spread
2017 StandoutNobel
Renal Fibroblasts and Myofibroblasts in Chronic Kidney Disease
2006
Systemic sclerosis: a prototypic multisystem fibrotic disorder
2007 Standout
Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
2020 Standout
Fibroblasts and myofibroblasts in wound healing
2014 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Matrix-Producing Cells in Chronic Kidney Disease: Origin, Regulation, and Activation
2013
Management of Chronic Kidney Disease Patients in the Intensive Care Unit: Mixing Acute and Chronic Illness
2017 Standout
Differential Contribution of Dermal Resident and Bone Marrow–Derived Cells to Collagen Production during Wound Healing and Fibrogenesis in Mice
2010
Insights into RNA Biology from an Atlas of Mammalian mRNA-Binding Proteins
2012 Standout
Dystrophin expression in the mdx mouse after localised and systemic administration of a morpholino antisense oligonucleotide
2005
Molecular mechanisms of muscular dystrophies: old and new players
2006
Transcriptional regulation of the human α2(I) collagen gene (COL1A2), an informative model system to study fibrotic diseases
2006
Enhancement of SMN2 Exon 7 Inclusion by Antisense Oligonucleotides Targeting the Exon
2007
Alternative Splicing: Therapeutic Target and Tool
2006
Fibrocytes in health and disease
2010
Renal fibrosis: novel insights into mechanisms and therapeutic targets
2010
Dystrophin levels as low as 30% are sufficient to avoid muscular dystrophy in the human
2007
Macrophages promote renal fibrosis through direct and indirect mechanisms
2014
Dysfunction of fibroblasts of extrarenal origin underlies renal fibrosis and renal anemia in mice
2011
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
2011 Standout
A Putative Src Homology 3 Domain Binding Motif but Not the C-terminal Dystrophin WW Domain Binding Motif Is Required for Dystroglycan Function in Cellular Polarity in Drosophila
2007 StandoutNobel
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
2009 StandoutNature
The gastrointestinal tract stem cell niche
2006
The origin of interstitial myofibroblasts in chronic kidney disease
2011
Local Dystrophin Restoration with Antisense Oligonucleotide PRO051
2007
Long Noncoding RNAs: Cellular Address Codes in Development and Disease
2013 Standout
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Gene regulation by long non-coding RNAs and its biological functions
2020 Standout
DLS and zeta potential – What they are and what they are not?
2016 Standout
Diverse origins of the myofibroblast—implications for kidney fibrosis
2015
Pericytes and Perivascular Fibroblasts Are the Primary Source of Collagen-Producing Cells in Obstructive Fibrosis of the Kidney
2008
Safety Pharmacology and Genotoxicity Evaluation of AVI-4658
2010
Comparative Analysis of Antisense Oligonucleotide Sequences for Targeted Skipping of Exon 51 During Dystrophin Pre-mRNA Splicing in Human Muscle
2007
Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development
2020
RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform
2010
FIBROCYTES IN HEALTH AND DISEASE
2011
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
CD4+T cells control the differentiation of Gr1+monocytes into fibrocytes
2009
Understanding the origin, activation and regulation of matrix‐producing myofibroblasts for treatment of fibrotic disease
2013
Body-wide gene therapy of Duchenne muscular dystrophy in the mdx mouse model
2006
Intestinal permeability – a new target for disease prevention and therapy
2014 Standout
miR‐31 modulates dystrophin expression: new implications for Duchenne muscular dystrophy therapy
2011
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Satellite Cells and the Muscle Stem Cell Niche
2013 Standout
Splicing of a Critical Exon of Human Survival Motor Neuron Is Regulated by a Unique Silencer Element Located in the Last Intron
2006
Tumor-associated fibroblasts predominantly come from local and not circulating precursors
2016
Mechanisms of Renal Fibrosis
2017 Standout
Tunable protein synthesis by transcript isoforms in human cells
2016 StandoutNobel
Microfluidic system for high throughput characterisation of echogenic particles
2014
A fusion peptide directs enhanced systemic dystrophin exon skipping and functional restoration in dystrophin-deficient mdx mice
2009
Works of J. Alter being referenced
Bone Marrow–Derived Cells Do Not Contribute Significantly to Collagen I Synthesis in a Murine Model of Renal Fibrosis
2006 Standout
Evaluation of Methods for Sizing and Counting of Ultrasound Contrast Agents
2012 Standout
Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology
2006 Standout
Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles
2004 Standout